Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Frassoni

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Cytotherapy|January 19, 2010
Intra-bone route of administration offers new perspectives for safer transplantation of hematopoietic stem cellsFrancesco Frassoni
The Lancet. Oncology|August 22, 2009
Anti-T-cell globulin: an essential ingredient for haematopoietic cell transplantation?Francesco Frassoni
Cytotherapy|March 18, 2015
Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulationMitchell E Horwitz, Francesco Frassoni
Current Opinion in Drug Discovery & Development|September 3, 2010
Emerging targets for hematological malignanciesDaniela Cilloni, Francesco Frassoni, Giuseppe Saglio
Haematologica|July 4, 2007
Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders?Franco Locatelli, Rita Maccario, Francesco Frassoni
Immunology Letters|October 2, 2013
New possibilities to exploit the potentiality of cord blood cells in the context of transplantationFrancesco Frassoni, Daniela Cilloni, Marina Podestà
Immunology Letters|October 12, 2013
Foreword. New frontiers in molecular and cellular therapyFrancesco Frassoni, Franco Locatelli, Lorenzo Moretta
Journal of Cellular and Molecular Medicine|April 6, 2026
Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTACDaniela Cilloni, Alessandro Ferrando, Francesco Frassoni
Regenerative Medicine|May 1, 2007
Stem cells for multiple sclerosis: promises and realityAntonio Uccelli, Francesco Frassoni, Gianluigi Mancardi
Haematologica|September 10, 2002
Imatinib: can one outwit chronic myeloid leukemia?Lucio Luzzatto, Francesco Frassoni, Junia V Melo
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Cytotherapy|January 19, 2010
Intra-bone route of administration offers new perspectives for safer transplantation of hematopoietic stem cellsFrancesco Frassoni
The Lancet. Oncology|August 22, 2009
Anti-T-cell globulin: an essential ingredient for haematopoietic cell transplantation?Francesco Frassoni
Cytotherapy|March 18, 2015
Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulationMitchell E Horwitz, Francesco Frassoni
Current Opinion in Drug Discovery & Development|September 3, 2010
Emerging targets for hematological malignanciesDaniela Cilloni, Francesco Frassoni, Giuseppe Saglio
Haematologica|July 4, 2007
Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders?Franco Locatelli, Rita Maccario, Francesco Frassoni
Immunology Letters|October 2, 2013
New possibilities to exploit the potentiality of cord blood cells in the context of transplantationFrancesco Frassoni, Daniela Cilloni, Marina Podestà
Immunology Letters|October 12, 2013
Foreword. New frontiers in molecular and cellular therapyFrancesco Frassoni, Franco Locatelli, Lorenzo Moretta
Journal of Cellular and Molecular Medicine|April 6, 2026
Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTACDaniela Cilloni, Alessandro Ferrando, Francesco Frassoni
Regenerative Medicine|May 1, 2007
Stem cells for multiple sclerosis: promises and realityAntonio Uccelli, Francesco Frassoni, Gianluigi Mancardi
Haematologica|September 10, 2002
Imatinib: can one outwit chronic myeloid leukemia?Lucio Luzzatto, Francesco Frassoni, Junia V Melo
Pageof 11